SecFilingDex
424B5SMMTCIK 0001599298

Summit Therapeutics Inc.

Prospectus supplement (424B5) filed .

Prospectus supplement filed under Rule 424(b)(5) for a takedown from an existing shelf registration statement.

Filing facts

Accession number
0001193125-24-136721
Filer
Summit Therapeutics Inc.
Ticker
SMMT
CIK
0001599298
Form type
424B5
Form description
Prospectus supplement
Filed at
May 13, 2024
Filing size
616.1 KB
Last verified
August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.